Design, development, and characterization of liposomes loaded with cefuroxime
DOI:
https://doi.org/10.47957/ijpda.v13i2.626Keywords:
Liposomes, Differential Scanning Calorimetry (DSC), Cefuroxime, Drug delivery system, Encapsulation efficiency (EE)Abstract
Liposomes have emerged as a promising drug delivery system due to their biocompatibility, biodegradability, and ability to enhance drug stability while minimising adverse effects. This study focuses on the formulation and characterisation of cefuroxime-loaded liposomes prepared using the thin lipid film hydration method. Nine formulations were developed using varying concentrations of soya lecithin and cholesterol, followed by vortexing for different durations. The prepared liposomes were evaluated for drug-excipient compatibility using DSC, particle size distribution, zeta potential, drug entrapment efficiency, and in vitro drug release kinetics. The optimized formulation (F9) demonstrated high drug entrapment efficiency (87.36%), nanoscale particle size (1246.4 nm), and a stable zeta potential (-47.2 mV). In vitro release studies revealed a controlled and sustained drug release profile following zero-order kinetics. The results indicate that increasing lipid concentration enhances drug encapsulation but slows drug release. These findings highlight the potential of liposomal formulations for improving cefuroxime delivery, stability, and therapeutic efficacy.
Downloads
References
Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomedicine. 2015;10(1):975-999
Mathiyazhakan, M., Wiraja, C., Xu, C., 2018. A Concise Review of Gold Nanoparticle-Based Photo-Responsive Liposomes for Controlled Drug Delivery. Nano-Micro Lett.
Kapoor, M., Lee, S.L., Tyner, K.M., 2017. Liposomal Drug Product Development and Quality: Current US Experience and Perspective. AAPS J. 19, 632–641.
Euliss, L.E., DuPont, J.A., Gratton, S., DeSimone, J., 2006. Imparting size, shape, and composition control of materials for nanomedicine. Chem. Soc. Rev.
Pattni, B.S., Chupin, V.V., Torchilin, V.P., 2015. New Developments in Liposomal Drug Delivery. Chem. Rev.. 115, 10938–10966.
Ça? gdas ¸, M., Sezer, A.D., Bucak, S., 2014. Liposomes as Potential Drug Carrier Systems for Drug Delivery, in: Application of Nanotechnology in Drug Delivery.
Lodise, T. P., & Patel, N. (2019). Cefuroxime: A review of its pharmacokinetics, spectrum of activity, and clinical applications. Expert Opinion on Pharmacotherapy, 20(10), 1209-1222.
Allen, T. M., & Cullis, P. R. (2013). Liposomal drug delivery systems: From concept to clinical applications. Advanced Drug Delivery Reviews, 65(1), 36-48.
Bush, K., & Bradford, P. A. (2016). ?-Lactams and ?-lactamase inhibitors: An overview. Cold Spring Harbor Perspectives in Medicine, 6(8), a025247.
Giske, C. G., Monnet, D. L., Cars, O., & Carmeli, Y. (2020). Clinical and microbiological aspects of cefuroxime resistance. Clinical Microbiology Reviews, 33(2), e00116-19.
Immordino, M. L., Dosio, F., & Cattel, L. (2006). Stealth liposomes: Review of the basic science, rationale, and clinical applications. Biotechnology Advances, 24(1), 52-89.
Torchilin, V. P. (2022). Liposomes: A versatile tool for drug delivery. Nature Reviews Drug Discovery, 21(4), 233-250.
Published
How to Cite
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
